Is Eledon Pharmaceuticals Inc (ELDN) overvalued? · $209.6M cap
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
This page asks whether Eledon Pharmaceuticals Inc (ELDN) looks expensive on cached numbers — not a short thesis.
No cached income statement for ELDN, so there is no earnings base to call rich or cheap.
ELDN currently screens at market cap $209.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ELDN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ELDN stock page for the full model, not this heading.
Not investment advice.